Not applicableStudy completedNCT06903754What this trial is testingISGLT2 in Patients Without DM With Acute MIWho this might be right forAcute Coronary SyndromesHeart Failure Mohammed VI University Hospital 450
Not applicableStudy completedNCT07332156What this trial is testingLung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. SulfonylureasWho this might be right forType 2 DiabetesCOPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis) Samsung Medical Center 21,692
Large-scale testing (Phase 3)Study completedNCT04304261What this trial is testingEffects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)Who this might be right forDiabetes Mellitus, Type 2Cognitive Functions Confusion Third Military Medical University 100
Not applicableNot Yet RecruitingNCT06739486What this trial is testingEfficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver DiseaseWho this might be right forNon Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more Assiut University 100
Not applicableStudy completedNCT02857764What this trial is testingSodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United StatesWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 127,690
Not applicableLooking for participantsNCT07601867What this trial is testingEffect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass GraftingWho this might be right forHeart FailureCoronary Arterial Disease Pyatigorsk City Clinical Hospital Number 1 72
Testing effectiveness (Phase 2)Study completedNCT04818034What this trial is testingThe Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary StudyWho this might be right forCystinuria University of California, San Francisco 10
Not applicableNot Yet RecruitingNCT07708610What this trial is testingPreadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 DiabetesWho this might be right forPneumoniaType 2 Diabetes Mellitus (T2DM) Chung Shan Medical University 71,775
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435What this trial is testingBeta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor AgonistsWho this might be right forType 2 Diabetes (T2DM) MaryAnn Banerji 60
Post-approval studies (Phase 4)Study completedNCT02914691What this trial is testingEffects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 DiabetesWho this might be right forType 2 DiabetesDiabetic Nephropathy Peter Rossing 40
Post-approval studies (Phase 4)UnknownNCT04340908What this trial is testingEffects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac SurgeryWho this might be right forDiabetes Mellitus, Type 2Cardiac Surgery Hongchang Guo 500
Post-approval studies (Phase 4)Study completedNCT05309785What this trial is testingSafety and Efficacy of Canagliflozin in Advanced CKDWho this might be right forESRDCKD Stage 4CKD Stage 5 McGill University Health Centre/Research Institute of the McGill University Health Centre 34
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878What this trial is testingRapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Who this might be right forChronic Kidney DiseaseType 2 Diabetes Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT02597049What this trial is testingDulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Eli Lilly and Company 424
Testing effectiveness (Phase 2)UnknownNCT04419337What this trial is testingPioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With StrokeWho this might be right forDiabetes MellitusStroke Chang Gung Memorial Hospital 200
Not applicableStudy completedNCT06453577What this trial is testingPharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart FailureWho this might be right forAcute Decompensated Heart Failure Universität des Saarlandes 33
Early research (Phase 1)Study completedNCT03560323What this trial is testingKetones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1Who this might be right forHeart FailureType 2 Diabetes Mellitus The University of Texas Health Science Center at San Antonio 41
Large-scale testing (Phase 3)Study completedNCT01387737What this trial is testingLong-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Tanabe Pharma Corporation 1,299
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326What this trial is testingDApagliflozin SC0062 and Prevention of Renal Injury; a Randomized EvaluationWho this might be right forType 1 Diabetes Mellitus With Diabetic Nephropathy University Medical Center Groningen 36
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985What this trial is testingEffect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 InhibitorsWho this might be right forDiabetes Mellitus, Type 2HyperglycemiaInsulin Resistance Yonsei University 100